Thiamine Supplementation in High Risk Cardiac Surgery Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 19, 2017

Primary Completion Date

May 18, 2018

Study Completion Date

June 18, 2018

Conditions
Cardiac Surgery
Interventions
DRUG

Thiamine hydrochloride (200mg) dissolved in 100 ml of normal saline

"* After anesthesia induction~* After separation from CPB~* On the evening of the day of surgery (22:00)~* On POD 1 twice a day at 8:00 and 22:00~* On POD 2 twice a day at 8:00 and 22:00 (if patient is still in ICU)~* On POD 3 twice a day at 8:00 and 22:00 (if patient is still in ICU)"

DRUG

Normal saline (100ml)

"* After anesthesia induction~* After separation from CPB~* On the evening of the day of surgery (22:00)~* On POD 1 twice a day at 8:00 and 22:00~* On POD 2 twice a day at 8:00 and 22:00 (if patient is still in ICU)~* On POD 3 twice a day at 8:00 and 22:00 (if patient is still in ICU)"

Trial Locations (1)

Unknown

Meshalkin Research Institute of Pathology of Circulation, Novosibirsk

All Listed Sponsors
lead

Meshalkin Research Institute of Pathology of Circulation

NETWORK

NCT03306732 - Thiamine Supplementation in High Risk Cardiac Surgery Patients | Biotech Hunter | Biotech Hunter